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A Heterozygous Frameshift Mutation in the V1
Domain of Keratin 5 in a Family with Dowling–Degos
Disease
Haihui Liao1, Yiwei Zhao1, David U. Baty2, John A. McGrath3, Jemima E. Mellerio3 and W.H. Irwin McLean1
Dowling–Degos disease (DDD) is an autosomal-dominant genodermatosis characterized by reticulate
pigmentation of the flexures. By direct DNA sequencing, we have identified a frameshift mutation in exon 1
of KRT5 in the proband from an extended Spanish DDD kindred. Cloning of PCR products confirmed that this
was a 2-bp deletion mutation, designated c.442delAG, leading to a premature termination codon in the V1
domain of the K5 polypeptide, designated p.S148fsX30. These data confirm that haploinsufficiency for K5 causes
DDD and points to a prominent role for the keratin intermediate filament cytoskeleton within basal
keratinocytes in epidermal pigment biology.
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INTRODUCTION
Dowling–Degos disease (DDD; OMIM No. 179850) is an
autosomal-dominant Mendelian disorder characterized by
hyperpigmented macules and papules in a reticulate pattern,
particularly affecting the flexures and other major skin folds
(Harper and Trembath, 2004). The disorder usually appears
and/or worsens after puberty. A number of DDD patients
have comedone-like follicular lesions, especially on the
neck. Importantly, there is no overt skin blistering and the
epidermal appendages are unaffected.
Recently, a genome-wide linkage scan localized the gene
for DDD to an interval containing the type II keratin gene
cluster and heterozygous loss-of-expression mutations were
found in the KRT5 gene encoding keratin K5 (Betz et al.,
2006). Mutation c.418dupA was found in five apparently
unrelated cases of DDD (Betz et al., 2006) and leads to a
frameshift and a premature stop codon, 39 codons down-
stream, p.I140fsX39. In a further three cases, a nonsense
mutation was detected very close to the start of exon 1 of
KRT5, c.14C4A; p.S5X (Betz et al., 2006). Both defects are
effectively null-mutations for K5 and none of the rod domain
sequences are expressed from these mutant alleles. Rod
domain defects interfere with keratin filament assembly
through dominant-negative interference and represent the
overwhelming majority of the reported keratin mutations
(Omary et al., 2004). Thus, it has been established that K5
haploinsufficiency, rather than a dominant-negative defect in
K5, underlies the dominant inheritance seen in DDD.
Here, we report a novel K5 frameshift mutation in an
extended kindred with DDD, confirming the nature of
genetic keratin defects causing this genodermatosis.
RESULTS
The proband was a 42-year-old Spanish woman. From the
age of 18 years, she began to develop areas of hyperpigment-
ation, initially on the face, but then affecting the neck,
axillae, beneath the breasts, and in the groin (Figure 1a–c).
The eruption has continued to become more extensive
throughout adulthood and she has generalized pruritus.
Examination revealed a symmetrical reticulate hyperpigmen-
ted dermatosis predominantly affecting the lower face, skin
folds, and major flexures. Around the neck and elbows, the
rash was more erythematous and papular. Hair and nails
were normal, acral sites were relatively spared, and
hypopigmentation was not a feature. Eight other family
members over three generations were also affected, typically
with post-pubertal onset of a progressive reticulate dermatosis
of the flexures, although in some individuals the changes
were confined to the neck/lower face.
A skin biopsy of lesional epidermis from the proband was
analyzed by conventional histology, which revealed numer-
ous finger-like downgrowths of the epidermis into the
underlying mesenchyme (Figure 1d). The epidermis was
acanthotic and there were many keratin-filled cysts resem-
bling comedones. Areas of hyperpigmentation were evident
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at higher power (data not shown). These features were
entirely consistent with the clinical diagnosis of DDD (Harper
and Trembath, 2004).
As the genetic basis of DDD was recently reported (Betz
et al., 2006), we focused genetic analysis on exon 1 of the K5
gene. Direct DNA sequencing of PCR products derived from
the proband revealed overlapping DNA bases indicative of a
heterozygous insertion/deletion mutation, when compared to
a control sequence (Figure 2a and b). This was predicted to
be a 2-bp deletion mutation, c.442delAG, which was
subsequently confirmed by cloning of the PCR products to
allow sequencing of the individual normal and mutant alleles
(Figure 2c). This frameshift mutation leads to a premature
TAA codon, which terminates protein translation 30 codons
downstream. In terms of its effect on protein translation, the
mutation is designated as p.S148fsX30 and truncates the K5
polypeptide within the V1 domain, well upstream of the rod
domain.
DISCUSSION
DDD is a relatively uncommon papillomatous pigmentary
defect showing autosomal-dominant inheritance. Here, we
have identified a novel heterozygous frameshift mutation in
exon 1 of the gene encoding K5 in a family bearing all the
clinical and histopathological hallmarks of DDD (Harper and
Trembath, 2004). Thus, there are now three known K5
mutations associated with the DDD phenotype in nine
families (Betz et al., 2006). All three of these mutations lead
to truncation of the K5 protein before the rod domain and are
effectively null-alleles. Although it is possible that a truncated
K5 V1 domain might be expressed to an appreciable level
from the c.442delAG mutant allele described here and the
c.418dupA allele reported previously, it has been shown that
overexpression of this peptide does not appear to perturb the
endogenous keratin filament network in MCF-7 cells (Betz
et al., 2006). With the clinical material available here, it was
not possible to check for expression of this peptide or perform
electron microscopy to look for dominant-negative effects on
the cytoskeleton. More importantly, the p.S5X nonsense
mutation is an unambiguous null-allele (Betz et al., 2006),
and so it would appear that haploinsufficiency is the
mechanism underlying the dominant inheritance observed
in DDD. Interestingly, there is no haploinsufficiency issue
with K14, as several families have been reported in which
K14 null-alleles cause recessive epidermolysis simplex
bullosa (EBS) (reviewed by Batta et al., 2000). In these
families, many parents and siblings heterozygous for K14
null-alleles have been identified, who have clinically normal
skin with neither epidermal blistering nor pigmentary
changes. Thus, the DDD mutations have revealed an
important difference between type I and II keratins in the





Figure 1. Clinicopathological features of the reticulate pigmented eruption.
(a) Numerous hyperpigmented papules on the neck; (b) grouped erythematous
papules below both breasts; (c) papules in the right infra-mammary fold
shown at higher magnification; and (d) light microscopy reveals acanthosis
with marked papillomatosis interspersed by keratin-filled invaginations (*)
and dermal pigmentary incontinence. Arrows indicate the many filiform
protrusions of the epidermis into the dermis. Bar¼ 0.1 mm.
Normal, codons 146–150 DDD, heterozygote Mutant clonea b c
Figure 2. Molecular genetic analysis of KRT5 in DDD. (a) Direct DNA
sequencing of exon 1 of KRT5, codons 146–150 (þ strand) from a normal
individual. An AG repeat is boxed. (b) The same stretch of sequence shown in
(a) derived from the proband. Overlapping sequences commence following
the first AG repeat (boxed), indicative of a frameshift mutation. (c) The
equivalent stretch of sequence derived from a cloned PCR fragment
corresponding to the mutant, deleted allele from the proband, confirming that
one of the AG repeats has been deleted (boxed). The genomic mutation is
designated as c.442delAG. The frameshift leads to a TAA codon 30 codons
downstream, designated as p.S148fsX30 in protein nomenclature.
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The genetic basis of DDD sheds further light on the
hitherto under-recognized role of the K5/K14 cytoskeleton, in
particular K5, in the trafficking of melanosomes. This is
supported by the fact that a recurrent mutation in the V1
domain of K5, P25L, causes epidermolysis bullosa simplex
with mottled pigmentation (EBS-MP; OMIM No. 131960), the
variant of EBS with mottled pigmentation (Uttam et al., 1996),
as reviewed in the keratin mutation database (http://www.in-
terfil.org). Similarly, a mutation in the V2 domain of K5 has
been reported in EBS-MP (Horiguchi et al., 2005). Although
much is known about the biogenesis of these pigmentary
organelles and their transfer via the dendritic processes of
melanocytes into basal keratinocytes (Hearing, 2005), com-
paratively little is known about how melanosomes are
transported within the keratinocyte and, specifically, what
targets them to their ultimate destination above the basal cell
nucleus. However, an abstract from the 2003 International
Investigative Dermatology meeting reported that a yeast two-
hybrid screen using part of the K5 V1 domain as bait resulted
in the identification of the dynein light-chain protein tctex-1,
a cytoplasmic cargo adaptor protein involved in intracellular
transport (Nobuhara et al., 2003). Importantly, the EBS-MP
mutation P25L in K5 was reported to disrupt this interaction.
Interestingly, a tctex-1 consensus binding site (Mok et al.,
2001) is also present at the C-terminus of K5 (RKSFKS-
COOH; consensus residues underlined). In rodents, K5 has
been shown to play an role in spermatogenesis where it forms
part of a unipolar nuclear cap in Sertoli cells (Kierszenbaum
et al., 2003a). Although K5/K14 expression in Sertoli cells has
not yet been reported in humans, it is likely that elements of
this mechanism are conserved across mammalian species.
Coincidentally, tctex-1 is also located in a nuclear cap
structure during spermatogenesis (Li et al., 2004). A link
between keratins and myosin Va has been suggested as a
mechanism for the pigmentary changes in DDD and
EBS-MP (Betz et al., 2006), supported by the fact that
mutations in this myosin gene cause Griscelli syndrome,
an inherited disorder affecting pigmentation (Marks and
Seabra, 2001). Myosin Va is also found in nuclear caps
during spermatogenesis (Kierszenbaum et al., 2003b).
Thus, both in Sertoli cells and in basal keratinocytes, K5,
tctex-1, and myosin Va may be involved in the formation of
nuclear caps for different biological purposes. Further
biochemical analysis of K5 protein–protein interactions
should clarify the unexpected role of this keratin in
positioning of melanosomes.
In conclusion, haploinsufficiency for K5 appears to be a
common genetic mechanism underlying DDD, shedding
light on an important accessory function of keratins in
relation to melanosome trafficking, in addition to their well-
established and critically important function in maintaining
the structural integrity of basal keratinocytes.
MATERIALS AND METHODS
Clinical material
An EDTA blood sample as obtained from the proband in Family 1
with written informed consent and local ethics approval that
complies with the Declaration of Helsinki Principles.
Mutation detection and confirmation
A 667-bp fragment spanning exon 1 of the KRT5 gene was amplified
by PCR using forward primer K5EX1F (50-CTC TCC AGC AAA TCC
CAA CC-30) and reverse primer K5EX1R (50-GGC ATT TAT TTC AGA
CCC ACA GT-30). Twenty five microliter PCR reactions were carried
out using Qiagen 10 PCR buffer containing 1.5 mM MgCl2 and 1 U
Qiagen Taq polymerase and the following program: 941C 5 minutes;
(941C 30 seconds, 581C 1 minute, 721C 2 minutes) 30 cycles; 721C
5 minutes. The fragment was sequenced with the amplification
primers above. To confirm the precise nature of the insertion/
deletion mutation, the PCR product was cloned into pCR2.1 vector
according to the manufacturer’s protocol (Invitrogen, Paisley, UK).
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